Latest Regulatory Milestones News

Finder Energy has secured A$27 million via a two-tranche placement plus a A$3 million share purchase plan to fast-track its KTJ oil project in Timor-Leste, aiming for final investment decision by mid-2026 and first oil by late 2027.

4DMedical has made significant strides in commercial adoption of its CT:VQ™ lung imaging technology, securing top US hospital contracts, regulatory approvals in Europe and the UK, and a major pharmaceutical partnership, all backed by strong capital raises and inclusion in the S&P/ASX 200.

Artrya has fully integrated its Salix platform at Tanner Health, is preparing two more US sites for launch, and is finalising FDA submission for its Coronary Flow module, backed by a strong cash position of $76.6 million.

Dimerix has completed adult patient recruitment in its Phase 3 ACTION3 trial for DMX-200, with a blinded review confirming the study remains statistically powered to demonstrate treatment efficacy. The company also appointed a new CFO and is negotiating up to US$50 million in non-dilutive funding.

D3 Energy has significantly expanded its South African helium footprint with new Exploration Rights and a Technical Cooperation Permit, while completing a well-supported A$6.12 million placement to fund upcoming drilling and development activities.

Metals X reported its fourth highest quarterly tin production at Renison with robust financials despite rising unit costs, while progressing the Rentails project and maintaining a strong cash position.

Maronan Metals secured Mineral Development Licence 2028, unlocking underground exploration, while metallurgical tests showed gold recoveries up to 88% and copper recoveries exceeding 96%. The company expanded its drilling program and bolstered leadership amid steady progress toward mine development.

Caravel Minerals has secured critical tenure and advanced engineering designs for its Caravel Copper Project, alongside non-binding debt interest of up to USD 220 million from European export credit agencies.

Optiscan Imaging has submitted its FDA dossier for InSpecta®, marking a crucial step toward US veterinary market entry, while progressing clinical studies for InVue® and InForm® ahead of further FDA submissions in 2026.

Beetaloo Energy has bolstered its financial footing with a $66.3 million equity placement and a $15.4 million R&D tax refund, underpinning key developments at the Carpentaria Gas Plant and local frac sand project.

QMines Limited reported a busy March quarter with strong drilling results at Mount Mackenzie, a resource upgrade at Develin Creek, and progress on the Mt Chalmers feasibility study, underpinned by a $15 million strategic funding package from QIC.

Jade Gas Holdings has completed its appraisal program at the Tavan Tolgoi coal bed methane project, preparing to lodge its maiden gas reserve booking and advance development plans backed by fresh capital.